内科三基试题-第六章-血液内科（The sixth chapter - three questions - Department of Hematology）

内科三基试题_第六章—血液内科(Thesixthchapter_three

questions_DepartmentofHematology)

ThesixthchapterHematologyDepartment

First,thenounexplanation

1.irondeficiencyanemia

2.severeaplasticanemia

3.PIEsyndrome

4.infectiousmononucleosis

5.D1C

6.celldeficiency

7.cellleukemialikereaction

8.EVen'ssyndrome

9.vonWillebranddisease

10.stemcells(stem,cell)

11.hematopoieticcelltransplantation(HSCT)

Two,individualchoicequestions

1.megaloblasticanemiabelongsto:()

A.smallcell,lowpigmentanemia,B.positiveanemia

C.,largecellanemia,D.,smallcellpositivepigmentedanemia

NomorethanE.

2.regardingmegaloblasticanemia,thefollowingoptionsare

incorrect:()

A.isalargecellanemiacausedbyfolicacidandvitaminB12

deficiency

B.megaloblasticanemiacanmanifestassymmetrical,limb

numbness,ataxia

Inadditiontoanemia,C.resultsinlargechangesin

granulocyteandlobulated

D.proliferationofcellsinallsystemsofthebodywillalso

occurlesions

ThemaincauseofE.isnotenoughfoodandnutrition

malabsorption

3.themostimportantdiagnosticcriteriaforaplasticanemia

are:()

A.wholebloodcellsdecrease,showinghemorrhageorinfection

B.meshreductionofreticulocytes

C.bonemarrowdysplasia

D.liver,spleenandlymphnodesarenotenlarged

InvalidE.ironandfolicacid

4.thefollowingdiseasescausethedecreaseofbonemarrow

megakaryocyte:()

A.hemophiliaB.irondeficiencyanemia

C.ITPD.aplasticanemia

E.megaloblasticanemia

5.haematologicalcharacteristicsofaplasticanemiaare:()

A.iswholebloodcelltodecrease,positivecellispigment

sexanaemia

ThesizeofB.cellsisdifferentandthecentralpaleareais

enlarged

C.showedincreasedmegakaryocytesandincreasedplatelet

countinthebloodsamples

D.granulocytesstagnateintheearlystageofimmaturegranule

withlargecytoplasm

E.bonemarrowhyperplasiaisactive,butmegakaryocytes

decrease

6.femalepatients,aged32,menstruationincreasewithfever

for2weeks,Hb50g/L,WBC/2.2X10.L,74%lymphocytes,

PLT16X10./L,bonemarrowhyperplasiaisextremelylow.The

mostlikelydiagnosisofthisdiseaseis:(a)

A.acuteleukemia,B.,severeaplasticanemia

C.acuteITPD.leukemiareaction

E.deficiency

7.,thewholebloodcellreduces,thebonemarrowproliferation

islow,thehematopoiesiscellreduces,thiskindofblood

picture,thebonemarrowimagedoesnotseein:()

A.depletedB.,lowproliferativeleukemia

C.AAD.PHN

E.myelofibrosis

8.aboutthedefinitionofhemolyticanemia,thefollowing

statementiscorrect:()

A.shortenedredcelllife

B.increasedredcelldestruction

C.hematopoietichyperfunctionofbonemarrow

D.increasedredcelldamageandcompensatedbonemarrow

E.increasedredcelldamage,exceedingthecompensatory

capacityofbonemarrow

9.thesiteofdestructionoferythrocytesinsituhemolysis

ismainly:()

A.liver,B.spleen

C.intravascularD.bonemarrow

NomorethanE.

10.thestartingsymptomsofacutehemolysisare:()

A.lowbackandlimbspain,headache,vomiting,chills,high

fever,etc

B.hemoglobinuria

C.shock

D.coma

E.renalfailure

11.whichofthefollowingdiseasesisantihumanglobulintest

positive:()

A.6glucose-6-phosphatedehydrogenase(G-6-PD)deficiency

B.marineanemia

C.hereditarymononucleosis

D.paroxysmalnocturnalhemoglobinuria

E.autoimmunehemolyticanemia

12.malepatients,35yearsold,halfayeartograduallyanemia,

fever,bleedingsymptoms,urineisathickdarkbrown,sclera

showedmildjaundice,liverandspleennotenlarged,Hb82g/

LWBC5.6~109/L,PLT93X/L109,reticulocyte5%.diagnosed

aspreferredwhichexamination:(a)

A.bonemarrowaspiration,B.,serumironquantification

C.

UrineD.testofhumanantiglobulin

E.acidifiedserumhemolysistest

13.irondeficiencyanemiaafteroraliron,theearliest

increaseis:(a)

A.hemoglobinB.whitebloodcellcount

C.mesh;reticulocytecount;D.;redbloodcellcount

NomorethanE.

14.whenirondeficiencyanemiaoccurs,thefollowingoptions

donotreduce:()

A.serumironB.totalironbindingcapacity

C.serumferritinD.transferrinsaturation

ThenumberofirongranulocytesintheE.bonemarrow

15.thefollowingresultsarenotconsistentwithhemolytic

anemia,asfollows:()

A.meshincreasesinreticulocytes

B.increasesmarrowmarrow

C.increasedurinaryexcretionofurine

D.increasedunconjugatedbilirubininblood

E.serumhaptoglobinincreased

16.male,50yearsold.Theleftepigastricfullnessafter

eatinghalfayear,intensified.Check:splenomagely,Hb80g

/LWBC/L,3.2x10.,850x10.BPC/L,thebloodthatteardrop

shapedredbloodcells,suspectedprimarymyelofibrosis.Most

helpfultotheexclusionofotherdiseasescausedbybloodthe

examinationofsecondarymyelofibrosisis:(a)

A.bloodsmearexamination,B.,blooduricaciddetermination

C:.bonemarrowbiopsy,D.bonemarrowaspiration+bonemarrow

biopsy

E.SplenicPuncture

17.,female,50yearsold,dizzinessandfatiguefor1years,

accompaniedbynauseaandvomitingforhalfamonth.Now

diagnosedwithmultiplemyelomaandrenaldysfunction(uremia).

Thepathogenesisis:()

A.coagulateproteinisdepositedinrenaltubularepithelial

cells

B.coagulatingproteindepositedinrenalgranuleepithelial

cells

C.hyperphosphatemiaistoohigh

D.highviscositysyndrome

E.dehydrationandinfection

18.polycythemiavera.Thefollowingresultsmaybereducedto:

0

A.,granulocytealkalinephosphatase,integral

B.erythropoietin

C.serumuricacid

D.serumgammaglobulin

E.serumvitaminB12bindingcapacity

19.patientswithsuspectedprimarybonefiber,thefollowing

symptomsdonotsupportthisdiagnosisis:(a)

A.canbeseenintheperipheralbloodofyoungandredblood

cells

B.thrombocytosis

C.hadlowintegralofgranulocytealkalinephosphatase

TeardroplikeredbloodcellswerefoundinD.bloodslices

E.reticulocytesincreasedslightly

20.thefollowingoptionsarenotconsistentwithpolycythemia

vera:()

A.whitebloodcell>12*10./L(nofever,infection)

Bplatelets>3000*10\L

C.decreasedbloodoxygensaturation

D.neutrophilalkalinephosphataseintegral>100score

E.fullbonemarrowhyperplasiawithmegakaryocytes

21.thebasisofdiagnosisforprimarythrombocytopeniadoes

notinclude:()

A.plateletcount>1000*10./L

B.bonemarrowhyperplasia,withmegakaryocytesasprominent,

hasalargenumberofplateletsformation

C.withoutbleedingtendency,.WBCjuicenumberdoesnot

increase

D.mostsplenomegaly

ExceptforE.,reactivethrombocytosisandother

myeloproliferativedisorders

22.ofthepatientswithlowbackpainforsixmonths,check

thepositiveurineprotein,osteolyticdamage,increased

immuneglobulin,themainconsiderationis:()

A.metastaticbonetumors

B.multiplemyeloma

C.Waldenstromglobulin

D.myelofibrosis

E.heavychaindisease

23.whichofthefollowingisnotachromosomalchangein

myelodysplasticsyndromes:()

A.one,5,B.,one,7

C.t(15:17)D.5aone

E.t8

24.themainhumoralfactorsthatregulateerythropoiesisare:

0

A.androgen,B.,estrogen

C.redcellextractD.colony-stimulatingfactor

E.EPO

Whichofthefollowing25.drugsisusedinthetreatmentof

myelodysplasticsyndromes:()

A.,retinoicacid,B.,glucocorticoids

C.CAGregimen,chemotherapy,D.

Thalidomide

E.aboveisOK

26.patientswithperipheralbloodplateletcountof2000^10.

/L;bonemarrowhyperplasiaandactivegrainerythroid

hyperplasia,megakaryocytewasactive,plateletlargeclusters

visible;FISHdetectionofba./ablfusiongenepositive

diagnosis.Thepatientsare:(a)

A.chronicmyelogenousleukemia,B.,primarythrombocytosis

C.polycythemiaveraD.myelofibrosis

E.infectiousthrombocytosis

27.iftheperipheralbloodofpatientswiththepresenceof

immatureerythrocytesandgranulocytes,teardropshapedred

bloodcells,bonemarrowstempumping,splenomegaly.Themain

considerationis:(a)

A.spleniclymphoma,B.,chronicmyelogenousleukemia

C.myelofibrosis,D.hemolyticanemia

E.aplasticanemia

28.multiplemyelomatreatmentoptions:()

A..B.hydroxyurea,interferon

C.byD.MaLilan

E.methylhydrazine

29.ofthefollowingoptions,notoneoftheclinical

manifestationsofDIC,is:()

A.hemorrhage,B.shock

C.embolism,symptom,D.,hemolysis

E.obstructivejaundice

30.female,14yearsold,paroxysmalabdominalpainandmelena

3days.Physicalexamination:thelowerlimbsscatteredin

purpura,bilateralkneejointswelling,1imitationofactivity,

theabdomenissoft,rightlowerabdominaltenderness.Hemogram:

WBC12.5X109/L,PLT100/X10.L.urineprotein+:RBC+/

HP,transparent.Tubetype0~3/LP.thediagnosismaybe:

(a)

A.acuteappendicitis,B.,mesentericlymphnodetuberculosis

C.acutenephritis,D.,acuteITP

HenochSchonleinpurpuraE.

31.female,15yearsold,menstruationincreasemorethan10

days.Check:anemia,skinscatteredbleedingpoints,liverand

spleenwerepalpable.Hb10g/L,WBC/10~10~L,BPC25~10.

/L.:bonemarrowhyperplasia,thevisiblemegakaryocyte50.

Thediagnosisis:(a)

A.aplasticanemia,B.,acuteleukemia

C.idiopathicthrombocytopenicpurpura,D.,Hypersplenism

E.systemiclupuserythematosus

32.glucocorticoidsarepreferredfor:()

A.sicklecellanemiaB.hereditarymononucleosis

C.marineanemiaD.paroxysmalnocturnalhemoglobinuria

E.resistanthemolyticanemia

33.peripheralbloodhasthediseasethatwholebloodcell

decreasesexcept:()

A.aplasticanemia

B.hypersplenism

C.paroxysmalnocturnalhemoglobinuria,}D.acuteleukemia,

reducedleukocytetype,:E.idiopathicthrombocytopenic

purpura

34.theprimaryexaminationsforidentificationofacute

myelogenousleukemiaandaplasticanemiaare:()

A.peripheralblooddecreasedinwholebloodandB.

granulocyteswerefoundinperipheralblood

C.nucleatedredbloodcellswerefoundinperipheralbloodof

D.,andbonemarrowexaminationwasnotaboveRandE.

35..Differentialdiagnosisofchronicmyelogenousleukemia

andmyeloidleukemia,itismeaningfulto:()

A.appearedinperipheralblood,andtherewereredbloodcells

inperipheralbloodofB.

C.Phichromosomepositive,D.eosinophilia

AbsolutevalueofreticulocytecountinE.net

36.Auercorpusclescanbeseeninthefollowingdiseases,but

shouldbeexcluded:()

A.acutemyeloidleukemia,B.,acutepromyelocyticleukemia

C.acutemonocyticleukemia,D.,acutemonocyticleukemia

E.acutelymphoblasticleukemia

37.nucleatedredbloodcellsarefoundinperipheralblood,

whicharefoundinthefollowingdiseasesexcept:()

A.myelofibrosisassociatedwithextramedullaryhematopoiesis

B.malignanttumor;bonemarrowmetastasis

C.Gglobinproducinganemia

D.sicklecellanemia

E.irondeficiencyanemia

38.patientswithfever,throatinflammation,lymphnode

enlargement,peripheralbloodlymphocytesincreased

significantly,andabnormallymphocytesappeared,positive

agglutinationtestshouldbeconsideredasfollows:()

A.

Malignantlymphoma,B.,acutelymphoblasticleukemia

C.tuberculosis,D.,infectiousmononucleosis

E.infectiousmononucleosis

39.thefollowingdiseasesdonotcauseeosinophilia:()

A.aplasticanemia,B.,bronchialasthma

C.psoriasis,D.,parasiticinfection

E.connectivetissuedisease

40.inthelaboratorydiagnosisofdisseminatedintravascular

coagulation,thefollowingoptionsareincorrect:()

A.thrombocytopenia

B.prothrombintimeislongerthannormal

C.decreasedfibrinogeninplasma

D.serumfibrinogen(J)cleavageproductsdecreasedby30%

E.brokencellsincreasedinbloodsamples

41.laboratoryexaminationofidiopathicthrombocytopenic

purpura,thefollowingoptionsarecorrect:()

A.hadnormalbleedingtime,prolongedclottingtime,and

normalclotretractiontime

B.bleedingtimeisprolonged,clottingtimeisnormal,andclot

contractiontimeispoor

C.prolongedbleedingtime,prolongedclottingtime,andpoor

clotcontractiontime

D.bleedingtimeisprolonged,clottingtimeisnormal,andclot

contractiontimeisnormal

E.hadnormalbleedingtime,normalclottingtime,andpoorclot

contractiontime

42.,thehistochemicalstainingfeaturesoftheevilgroupare

asfollows:()

A.ispositivefortrypsin(chymotrypsin)

Angiotensinconvertingenzymepositive,B.

C.acidphosphataseispositiveandcanbeinhibitedbytartaric

acid

D.non-specificesterasestainingpositive,canbeinhibited

bysodiumfluoride

E.increasedthealkalinephosphataseintegralofneutrophils

43..Theprognosisoflymphomaisrelatedtoitspathological

type.Thefollowingstatementsabouttheprognosisoflymphoma

areincorrect:()

ThepredominantlymphocytetypeinA.HDisthebestprognosis

B.HDtheprognosisofchildrenandelderlyisgenerallybetter

thanthatofthemiddle-agedandtheyoung

Theprognosisoflymphoblasticlymphomainc.NHLispoor

IntheearlystageofD.NHL,extranodalinvasionor

hematogenousdisseminationoccurs,andtheprognosisispoor

E.NHLlesionsat2ormoresitessuggestapoorprognosis

44.Hodgkin'sdiseasepatientshavefever,neckandarmpit

lymphnodeenlargement,otherlymphnodeareaandvisceraare

notinvolved,clinicalstagebelongsto:()

A.II,A,B.,II,B

C.Ill,A,D.,III,B

E.IVB

45.female,78yearsold.Superficiallymphnodesfor3years,

nearly2monthstoappearobviousemaciationandweaknesswith

skinitching.Theliverribs1cm,4cm.laboratoryexamination

spleenrib:Hb86g/L,WBC/56X10.L,BPC10.120X/L.of

bonemarrowhyperplasiaobviouslyactive.80%lymphocytes,

withmaturesmalllymphocytes,erythroid,myeloidhyperplasia

decreased.Serumproteinelectrophoresisrevealedthatgamma

globulindecreased.Thelymphnodebiopsyshowedlymphoid

hyperplasia,withsmalllymph.Differentmacrophage

agglutinationtestwasnegative.Themostlikelydiagnosisin

thiscaseis:(a)

A.acutelymphoblasticleukemia,B.,chroniclymphocytic

leukemia

C.lymphoma,D.,infectiousmononucleosis

E.infectiousmononucleosis

46.differentiatebetweenmyeloidleukemiaresponseand

chronicmyelogenousleukemia,thefollowingoptionsare:()

A.thewhitebloodcellwaslessthan150;(10./L

B.theneutrophilsoftheformeroftenhavetoxicgranules

C.theperipheralbloodbasophilswerenotincreasedinthe

former

D.intheformer,thealkalinephosphataseofneutrophilswas

low

E.theformerPhchromosomeisnegative

47.regardingtheprinciplesofchemotherapyforleukemia,the

followingoptionsareincorrect:()

A.combinedchemotherapymaybeadministeredwithdifferent

pharmacologicalactionsanddifferenttoxicities

B.combinedchemotherapycanonlyusecellcyclespecificdrugs

C.synchronizationistheuseofdrugstoenablemoreleukemic

cellstoenteraphaseofcellproliferationcycle

simultaneously

D.inducedremissionshouldbetreatedwithlargedosesand

intermittentdrugs

E.

Thenumberofwhitebloodcellsoccurredearliest

Thechangeis:()

A.lymphocyteB.monocyte

C.neutrophils,D.,eosinophils

E.basophil

61.splenicimagingisnotused:()

ThesizeofspleenwasdeterminedbyA.

DifferentialdiagnosisofleftupperquadrantmassinB.

DetectionofaccessoryspleeninC.

D.suspectedthediagnosisofsplenicruptureorabdominal

injuryhematoma

NomorethanE.

62.theindicationsinthefollowingoptionsarenotplasma

exchange:()

A.thromboticthrombocytopenicpurpura

B.isnotassociatedwithmultiplemyeloma.Renalfailure

C.hyperviscositysyndromecausedbyhighviscosity

D.coldagglutinationwithseverehemolysis,othertreatments

areineffective

E.removescoagulationfactorinhibitors

63.treatmentofhemophiliaAbleedingshouldnotbetransfused:

0

A.factorVIIIB.cryoprecipitate

C.freshfrozenplasmaD.prothrombincomplex

E.DDAVP(1-,-8-,Arg,Arg,vasopressin)

64.treatmentofhemophiliaBbybleedinginfusionof

prothrombincomplexshould:()

A.honceevery8B.,onceevery12h

C.onceaday,D.,thenextday

E.twotimesaweek

65..HematuriaoccursinpatientswithvonWillebranddisease.

Thefollowingtreatmenterrorsare:()

A.DDAVP(1-,deamination,-8-，argininevasopressin)

B.freshfrozenplasma

C.coldsediment

D.FVIIIconcentrate

E.aminocaproicacid

66.shouldbecarefulornotwithwholeblood:()

A.heartfailurepatients

B.acutetrauma,

C.majorsurgery,suchasbypasssurgery,cardiopulmonary

bypass

D.massivebloodloss

E.organtransplantation

67.donotloseplateletswhendigestivetractbleedingoccurs:

0

A.idiopathicthrombocytopenicpurpura

HenochSchonleinpurpuraB.

C.plateletweakness

D.aplasticanemia

E.acuteleukemia

68.disordersthatarenottreatedwithcorticosteroidsare:

0

A.HenochSchonleinpurpuraB.idiopathicthrombocytopenic

purpura

C.,plateletweakness,D.lymphoma

E.myeloma

69.humanbloodstemcellsarefirstseenin:()

A.extraembryonicyolksac,bloodisland,B.,extraembryonic

allantoicbase

C.aorticwall,D.,aorta,onegonad,onerenalregion

E.liver

70.,thebonemarrowisalifelonghematopoieticorgan,the

fetusbegantohematopoieticstart:()

A.7weeksB.8weeks

C.9weeksD.10weeks

E.11weeks

71.thelifespanofnormalhumanerythrocytesis:()

A.120days,B.150days

C.180days,D.200days

E.300days

72.directevidenceofengraftmentbyhematopoieticstemcell

transplantationdoesnotinclude:()

A.recipientsdetectedthedonor，ssexchromosomes

B.HLAantigen

C.redcellantigen

MoleculargeneticmarkersforD.donors(DNArestriction

fragmentpolymorphism)

E.presentedwithgraftversushostdisease(GVHD)

73.earlycomplicationsofhematopoieticstemcell

transplantationare:()

A.hemorrhagiccystitis(HC),interstitialpneumonitisofB.

(IP)

C.endocrinedysfunctionsecondarytoD.tumor

E.cataract

74.themainsitesofplateletdestructioninadultsare:()

A.1iver,B.spleen

C.bonemarrowD.bloodcirculation

E.ormore

75.characteristiccytogeneticabnormalitiesinchronic

myeloidleukemiacellsinvolvingchromosomes:()

A.9and11,numbersB.9and15

C.9and22,numbersD.15and17

E.5andIL

76.whatiswrongwithautosomaldominantgeneticdisordersis:

0

TheA.causativegeneispresentontheautosomalbasisinB.,

wherebothparentsareaffected

C.menandwomenhaveanequalchanceofgettingsick,andD.

childrenhavea25%chanceofgettingsick

NomorethanE.

77.latecomplicationsofhematopoieticstemcell

transplantationare:()

A.hemorrhagiccystitis(HC),B.hepaticvenoocclusivedisease

C.acutegraftversushostdisease,D.,cataract

NomorethanE.

78.thefollowingquestionsabouthematopoieticstemcell

transplantationarecorrect:()

A.allo-HSCTgenerallyrequiresrecipientsundertheageof50

B.auto-HSCTandthesamegeneHSCTcanbeextendedtotheage

of60

C.patientsundergoingtransplantationshouldnothaveserious

heart,liver,lung,kidneyandotherimportantorgan

dysfunction

D.patientsundergoingtransplantationshouldnotsufferfrom

severementaldisorders

E.ormorearecorrect

Three,yesandnoquestions

1.patientswithirondeficiencyanemiaistheprimary

principleofironsupplement().

2.irondeficiencyanemiaironsupplementationtorestore

normalhemoglobincanbediscontinued.()

3.megaloblasticanemiaisoftenassociatedwithneurological

symptoms

4.,thewholebloodcellinthehemogramisreduced,andthe

proliferationofbonemarrowsmearisreduced,sotheaplastic

anemiacanbediagnosed

5.aplasticanemiaisgenerallynotassociatedwith

hepatosplenomegaly().

6.eosinophiliceosinophiliashowedpositiveagglutination

test

7.eosinophiliacanbeseeninthefollowingdiseases:

bronchialasthma,psoriasis,infectiousmononucleosis,non

Hodgkinlymphoma,ovariancancer,adrenalhypofunction,

vasculitis().

8.primaryunknownmonoclonalglobulinisamalignantdisease

9.Waldenstromischaracterizedbyavarietyofcoagulationand

plateletabnormalities

10.multiplemyelomawithBenceJonesproteinuria().

11.phlebotomyisoneofthetreatmentmodalitiesfor

polycythemiavera

12.donotsmokewhenbonemarrowaspirationisgivento

patientswithmyelofibrosis

13.myelodysplasticsyndromescanhavemorbidhematopoiesis

14.peripheralbloodcanbediagnosedasleukemiabythe

appearanceofprimitivecells

15.patientswithgenuineredbloodcellsoftenshowredness

oftheface

16.patientswithHenochSchonleinpurpuramayhaveabdominal

pain,hemorrhagicenteritisorjointpain2weeksbeforethe

onsetofpurpura

17.bothHenochSchonleinpurpuraandthrombotic

thrombocytopenicpurpuracandevelophematuriaandproteinuria

18.hemophiliaAisanautosomalrecessivedisease

19.radiationdamageofbonemarrowisnotrelatedtoradiation

dose

20.ABObloodgroupincompatibilityoftenresultsin

intravascularhemolysisandextravascularhemolysis

21.matureerythrocyteshavenonuclei,buthavetheability

tosynthesizeproteinsandlipids

22.theglobinpeptidechainofhemoglobinisdividedintotwo

categories:Aandbeta.Eachhemoglobinmoleculeisconnected

byaapeptidechainandtwobetapeptidechains.Eachglobin

chaincontainsoneheme

Twenty-three

Indirectevidenceofengraftmentinhematopoieticstemcell

transplantrecipientsdetectedthesexchromosomesofthedonor

24.hemophiliaAandBareX1inkedgeneticdisorders

25.,ovalcellhyperplasiaisanautosomaldominantdisease

Thedifferentiationbetween26.typesofleukemiaandchronic

myelogenousleukemiaisusuallyalkalinephosphatasestaining

ofneutrophils

Radiotherapyforstage27.,stageIII,stageAnonHodgkin

lymphomaismainlybasedonradiotherapy

28.Helicobacterpyloriisassociatedwithlymphoma

29.acutepromyelocyticleukemiausuallyshowsdisseminated

intravascularcoagulationintheearlystageofthedisease

30.chronicmyelogenousleukemiaisusuallynotverysplenic

Four.Fillintheblanks

1.whendiagnosingirondeficiencyanemia,serumiron,total

ironbindingcapacity>,transferrinsaturation<

2.immunosuppressiveagentsforaplasticanemiainclude,,.

3.thetreatmentofautoimmunehemolyticanemiamainly

includes,,.

4.diseasesrequiringtheidentificationofaplasticanemia,

includingaplasticanemia,include,,.

5.clinicalfeaturesofhereditarymononucleosisinclude,,,.

6.theimmunophenotypeofchroniclymphocyticleukemiamainly

includes:CD19,CD20,CD23,CD79a